New hope for patients with Treatment-Resistant autoimmune disease
Disease control
Completed
This study tested whether the medication upadacitinib could help adults with Behcet's syndrome whose symptoms weren't controlled by standard treatments. Twenty-seven patients took the drug daily for 48 weeks alongside their existing medications. Researchers monitored whether symp…
Phase: PHASE2 • Sponsor: Liu Tian • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC